30
Participants
Start Date
September 9, 2021
Primary Completion Date
September 13, 2024
Study Completion Date
September 13, 2024
ADCT-901
Intravenous infusion
(START) Madrid - Hospital Universitario Fundación Jiménez Díaz Location, Madrid
Universidad Complutense de Madrid - Hospital Universitario 12 de Octubre, Madrid
Emory University, Winship Cancer Institute, Atlanta
University Hospitals of Cleveland Medical Center (UHCMC), Cleveland
Northwestern University, Chicago
Sarah Cannon at University of Oklahoma Health Sciences Center, Oklahoma City
NEXT Oncology, San Antonio
Sarah Cannon at HealthONE, Denver
Yale Cancer Center, New Haven
Institut Catala D'oncologia (ICO) - Hospital Duran I Reynals Location, Badalona
Hospital Universitari Vall D'hebron - Vall D'hebron Institut D'oncologia (VHIO), Barcelona
Imperial College Healthcare NHS Trust - St Mary's Hospital, London
Sarah Cannon Research Institute (SCRI) - London (SCRI-UK), London
Lead Sponsor
ADC Therapeutics S.A.
INDUSTRY